The benefits of a red-light laser treatment for myopia may come at the risk of c...
Medicare has different standards than the FDA. That’s how it should be.
England evaluates vaccine procurement and pandemic preparedness, whilst Moderna’...
Carcinotech has gained funding to enter the North American market with the compa...
LimmaTech announced the closing of a second round of its Series A financing, sec...
The US Food and Drug Administration (FDA) has granted fast track designation (FT...
Graviton Bioscience has secured a strategic investment from Sanofi to propel the...
The US FDA has granted rare paediatric disease (RPD) designation for Tyra Biosci...
Merck & Co (MSD) has reported a 1% revenue increase from 2022, and may face setb...
Bristol Myers Squibb has reported a 2% revenue decrease from 2022 as it focuses ...
With TGR-63 advancing towards the clinical stage, IGC Pharma is tackling differe...
AbbVie’s Tepkinly has been recommended for the treatment of relapsed or refracto...
The government wants to cut the average benchmark payments for 2025 Medicare Adv...
STAT's John Wilkerson was in the room as a judge questioned AstraZeneca lawyers ...
A Wednesday hearing on Covid origins “could have been an email,” two congressmen...
The WTO appears close to rejecting a waiver on intellectual property protection ...
